Mukka Proteins Limited Updates Insider Trading Code With Board Approval

Mukka Proteins Limited recently made amendments to its insider trading code, which was approved by the Board on February 12, 2026, in compliance with SEBI regulations. The updated code, which is based on the recommendation of the Audit Committee, provides clear guidelines for designated persons who are subject to insider trading regulations.

Key provisions of the amended code include the definition of designated persons, categories of Unpublished Price Sensitive Information (UPSI), trading restrictions, pre-clearance requirements, and the establishment of a digital database maintenance system. Designated persons covered by the code include promoters, members of the Board of Directors, executive directors, key executives, and their immediate relatives.

The code defines UPSI as information that is not generally available and could impact securities prices significantly. Categories of UPSI include financial results, changes in capital structure, mergers or acquisitions, key managerial personnel changes, fraud, defaults, regulatory actions, and litigation outcomes.

The amended code sets strict trading restrictions for designated persons in possession of UPSI, requiring them to obtain pre-clearance before executing any transactions in company securities. Designated persons must hold acquired securities for a minimum of six months and report transactions within two trading days. The Compliance Officer, Kalandan Mohammed Althaf, is responsible for maintaining a digital database with details of UPSI and persons with whom information is shared.

Violations of the code may result in disciplinary action, penalties, debarment, suspension, or criminal prosecution. The company is required to inform stock exchanges promptly of any violations observed by the Board of Directors. Additionally, the code clarifies that company disciplinary actions do not prevent regulatory authorities from taking separate enforcement actions.

The amendments to the code are available on the company’s website and have been communicated to both the NSE and BSE for dissemination to market participants.

In a separate development, Mukka Proteins Limited’s board approved the acquisition of 2,000 equity shares in its subsidiary, Haris Marine Products Private Limited, for a total consideration of Rs. 19.64 lakh on February 12, 2026. This acquisition, expected to be completed by June 30, 2026, will increase Mukka Proteins’ shareholding in Haris Marine Products from 98% to 100%, making it a wholly owned subsidiary.

Haris Marine Products, which operates in the fish meal and fish oil manufacturing industry, was incorporated in October 2019 and has a paid-up capital of Rs. 1,00,00,000. The subsidiary’s revenue performance over the past few years has shown fluctuations, with revenue figures varying from year to year.

The strategic acquisition aligns with Mukka Proteins’ expansion plans in the fish meal and fish oil manufacturing sector, demonstrating the company’s commitment to strengthening its position in the industry.